Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

Is More Better in SCLC? Triplets vs. Platinum/Etoposide
Mon, 11/05/2007 - 23:12
Author
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

We've always been tempted to see if we can add more to standard approaches to improve our outcomes. In SCLC, people have attempted to add taxol to cisplatin and etoposide as part of the PET regimen (platinum + etoposide + taxol). Although heavily tested, it clarified that triplet therapy with standard chemo for SCLC appears to be associated with no improvement in outcomes but with a very significant improvement in side effects, including risk of dying from treatment.

In the late 1990s, when taxol was still one of the newer drugs for lung cancer, several groups, including SWOG, CALGB, and a Greek lung cancer group ran small clinical trials that looked promising for a few dozen trials. However, the Greak Lung Cancer Cooperative Group reported results of a randomized trial that closed early, comparing cisplatin/etoposide to the triplet that added taxol, having included 133 patients with either LD-SCLC or ED-SCLC (paper here):

Mavroudis schema PET vs PE

(Click on image to enlarge)

Despite giving G-CSF (white blood cell growth factor) support in order to reduce potential toxicity, the study showed that patients getting the triplet didn't do any better and had far worse drops in blood counts and a significant increase in deaths due to treatment:

Mavroudis results PET vs PE

(neutropenia is low white cells, and thrombocytopenia is low platelets).

But this wasn't a huge trial, and perhaps the PET triplet looked bad for this one study.

Unfortunately, it didn't fare any better in a trial across North America (an Inter-group trial including the various cancer cooperative study groups)(abstract here). This was much larger and had the same basic design of standard doublet platinum-etoposide vs. PET triplet, and it included nearly 600 patients with ED-SCLC:

Niell Intergroup PET vs PE

As with the Greek trial, the triplet was associated with essentially identical activity, but the rate of dying from treatment was more than doublet with the triplet (and the WBC growth factor protected people with the PET triplet from low WBCs but not low platelets).

Niell PET vs PE results

These two studies have pretty much clarified that the PET triplet is dangerous and doesn't add anything, and I suspect we'd find similar results with other triplets with standard chemo. As noted in a prior post, doublet chemo with a targeted agent like avastin is feasible, but it's not clear that it really adds anything either. Platinum and etoposide may be the same regimen we've been using for more than a decade, but only because it has withstood the test of time and many challengers thus far.

Next Previous link

Previous PostNext Post

Related Content

Forum Discussions

Hi and welcome to GRACE.  I'm sorry mother is experiencing oligoprogrssion.  This often happens when some of the cancer cells acquire a resistance to alecensa's effects.  Those cells can be radiated...

help Mom to continue using Alectinib. Thank you for the video list as well. Is there any experience or some period in which SBRT works, is it individual or are there...

Oh yes! SBRT (Stereotactic body radiation therapy) is a very focused type of radiation that is able to target and kill the tumor without the destruction of healthy tissue. The goal...

Hello and welcome to GRACE.  I'm so sorry about your person.  Cancer is a horrible disease.  We can't diagnose or interpret scans here nor should you expect anyone else to make...

Hi sbunit and welcome to Grace.  I'm sorry about your mom and you need to be here looking for answers.  Unfortunately there just aren't good answers to these questions.  But yes...

Recent Comments

JOIN THE CONVERSATION
Oh yes! SBRT (Stereotactic…
By JanineT Forum … on Wed, 11/30/2022 - 11:54
Oligo
By JanineT Forum … on Wed, 11/30/2022 - 02:11
Hi, I'm sorry that I missed…
By JanineT Forum … on Tue, 11/29/2022 - 14:57
Hi and welcome to GRACE.  I…
By JanineT Forum … on Mon, 11/28/2022 - 14:35